Abstract
Transforming growth factor beta (TGF-β) has been recognized as an important mediator in the genesis of chronic kidney diseases (CKD), which are characterized by the accumulation of extracellular matrix (ECM) components in the glomeruli (glomerular fibrosis, glomerulosclerosis) and the tubular interstitium (tubulointerstitial fibrosis). Glomerulosclerosis is a major cause of glomerular filtration rate reduction in CKD and all three major glomerular cell types (podocytes or visceral epithelial cells, mesangial cells and endothelial cells) participate in the fibrotic process. TGF-β induces (1) podocytopenia caused by podocyte apoptosis and detachment from the glomerular basement membrane; (2) mesangial expansion caused by mesangial cell hypertrophy, proliferation (and eventually apoptosis) and ECM synthesis; (3) endothelial to mesenchymal transition giving rise to glomerular myofibroblasts, a major source of ECM. TGF-β has been shown to mediate several key tubular pathological events during CKD progression, namely fibroblast proliferation, epithelial to mesenchymal transition, tubular and fibroblast ECM production and epithelial cell death leading to tubular cell deletion and interstitial fibrosis. In this review, we re-examine the mechanisms involved in glomerulosclerosis and tubulointerstitial fibrosis and the way that TGF-β participates in renal fibrosis, renal parenchyma degeneration and loss of function associated with CKD.
Similar content being viewed by others
References
Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E (1996) Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148–155
Akaoka K, White RHR, Raafat F (1995) Glomerular morphometry in childhood reflux nephropathy, emphasizing the capillary changes. Kidney Int 47:1108–1114
Alvarez-Muñoz P, Mauer M, Kim Y, Rich SS, Miller ME, Russell GB, López-Novoa JM, Caramori ML (2010) Cellular basis of diabetic nephropathy. V. Endoglin expression levels and diabetic nephropathy risk in patients with type 1 diabetes. J Diabetes Complications 24:242–249
Arciniegas E, Sutton AB, Allen TD, Schor AM (1992) Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 103:521–529
Baricos WH, Cortez SL, Deboisblanc M, Xin S (1999) Transforming growth factor-β is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 10:790–795
Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC (2003) Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284:F955–F965
Border WA, Noble NA (1997) TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388–1396
Bottinger EP (2007) TGF-β in renal injury and disease. Semin Nephrol 27:309–320
Chanson M, Derouette JP, Roth I, Foglia B, Scerri I, Dudez T, Kwak BR (2005) Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta 1711:197–207
Chen HC, Chen CA, Guh JY, Chang JM, Shin SJ, Lai YH (2000) Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes. Life Sci 67:2345–2353
Chen R, Huang C, Morinelli TA, Trojanowska M, Paul RV (2002) Blockade of the effects of TGF-beta1 on mesangial cells by overexpression of Smad7. J Am Soc Nephrol 13:887–893
Chen S, Kasama Y, Lee JS, Jim B, Marin M, Ziyadeh FN (2004) Podocyte-derived vascular endothelial growth factor mediates the stimulation of α3(IV) collagen production by transforming growth factor-α1 in mouse podocytes. Diabetes 53:2939–2949
Cheng J, Grande JP (2002) Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood) 227:943–956
Chiarelli F, Gaspari S, Marcovecchio ML (2009) Role of growth factors in diabetic kidney disease. Horm Metab Res 41:585–593
Chin BY, Mohsenin A, Li SX, Choi AM, Choi ME (2001) Stimulation of pro-alfa1(I) collagen by TGF-beta1 in mesangial cells: role of the p38 MAPK pathway. Am J Physiol Renal Physiol 280:F495–F504
Cogan MG (1980) Medical Staff Conference. Tubulo-interstitial nephropathies—a pathophysiologic approach. West J Med 132:134–140
Cortes P, Riser BL, Yee J, Narins RG (1999) Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications. Nephrol Dial Transplant 14:1351–1354
Couser WG (1998) Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 13:10–15
Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P (2003) Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52:1031–1035
Das F, Ghosh-Choudhury N, Kasinath BS, Choudhury GG (2010) TGFβ enforces activation of eukaryotic elongation factor-2 (eEF2) via inactivation of eEF2 kinase by p90 ribosomal S6 kinase (p90Rsk) to induce mesangial cell hypertrophy. FEBS Lett 584:4268–4272
De Vecchi AF, Dratwa M, Wiedemann ME (1999) Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 14 (Suppl 6):31–41
Diamond JR, Ricardo SD, Klahr S (1998) Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 18:594–602
Diez-Marques L, Ortega-Velazquez R, Langa C, Rodríguez-Barbero A, López-Novoa JM, Lamas S, Bernabeu C (2002) Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis. Biochim Biophys Acta 1587:36–44
Ding G, Pesek-Diamond I, Diamond JR (1993) Cholesterol, macrophages, and gene expression of TGF-β1 and fibronectin during nephrosis. Am J Physiol Renal Physiol 264:F577–F584
Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, Singhal PC (2002) Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 283:F173–F180
Docherty NG, O'Sullivan OE, Healy DA, Murphy M, O'Neill AJ, Fitzpatrick JM, Watson RW (2006) TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 290:F1202–F1212
Dorado F, Velasco S, Esparís-Ogando A, Pericacho M, Pandiella A, Silva J, López-Novoa JM, Rodríguez-Barbero A (2008) The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation. Nephrol Dial Transplant 23:3403–3411
Eddy AA (1996) Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495–2508
Eddy AA (2000) Molecular basis of renal fibrosis. Pediatr Nephrol 15:290–301
Esteban V, Ruperez M, Vita JR, López ES, Mezzano S, Plaza JJ, Egido J, Ruiz-Ortega M (2003) Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. Kidney Int Suppl 86:S33-S38
Fogo AB, Kon V (2010) The glomerulus—a view from the inside—the endothelial cell. Int J Biochem Cell Biol 42:1388–1397
García-Sánchez O, López-Hernández FJ, López-Novoa JM (2010) An integrative view on the role of TGF-β in the progressive tubular deletion associated with chronic kidney disease. Kidney Int 77:950–955
Gharaee-Kermani M, Wiggins R, Wolber F, Goyal M, Phan SH (1996) Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. Am J Pathol 148:961–967
Gonzalez-Avila G, Vadillo-Ortega F, Perez-Tamayo R (1988) Experimental diffuse interstitial renal fibrosis. A biochemical approach. Lab Invest 59:245–252
Gould SE, Day M, Jones SS, Dorai H (2002) BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61:51–60
Goumans MJ, Zonneveld AJ van, Dijke P ten (2008) Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? Trends Cardiovasc Med 18:293–298
Grande MT, López-Novoa JM (2009) Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 5:319–328
Grande MT, Fuentes-Calvo I, Arévalo M, Heredia F, Santos E, Martínez-Salgado C, Rodríguez-Puyol D, Nieto MA, López-Novoa JM (2010a) Targeted disruption of H-Ras decreases renal fibrosis after ureteral obstruction in mice. Kidney Int 77:509–518
Grande MT, Perez-Barriocanal F, López-Novoa JM (2010b) Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy. J Inflamm (Lond) 22:19
Gruden G, Zonca S, Hayward A, Thomas S, Maestrini S, Gnudi L, Viberti GC (2000) Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49:655–661
Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW (1999) TGF-β1 activates MAP kinases in human mesangial cells: a possible role in collagen expression. Kidney Int 56:1710–1720
Hirschberg R, Wang S, Mitu GM (2008) Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 331:485–493
Hoffman BB, Sharma K, Ziyadeh FN (1998) Potential role of TGF-beta in diabetic nephropathy. Miner Electrolyte Metab 24:190–196
Humphreys BD, Duffield JS, Bonventre JV (2006) Renal stem cells in recovery from acute kidney injury. Minerva Urol Nefrol 58:329–337
Huwiler A, Pfeilschifter J (1994) Transforming growth factor β2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett 354:255–258
Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K (2005) Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 54:2891–2903
Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S (2002) Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62:901–913
Inoki K, Haneda M, Ishida T, Mori H, Maeda S, Koya D, Sugimoto T, Kikkawa R (2000) Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-β in mesangial cells. Kidney Int Suppl 77:S76–S80
Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E (1993) Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597–2601
Ito Y, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853–861
Kisseleva T, Brenner DA (2008) Fibrogenesis of parenchymal organs. Proc Am Torac Soc 5:338–342
Kitamura M, Suto TS (1997) TGF-β and glomerulonephritis: anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12:669–679
Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS (1996) Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74:991–1003
Kriz W, Kaissling B, Le Hir M (2011) Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 121:468–474
Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770–774
Lebrin F, Deckers M, Bertolino P, ten Dijke P (2005) TGF-beta receptor function in the endothelium. Cardiovasc Res 65:599–608
Lee HS (2011) Pathogenic role of TGF-β in the progression of podocyte diseases. Histol Histopathol 26:107–116
Lee LK, Meyer TM, Pollock AS, Lovett DH (1995) Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96:953–964
Lenda DM, Kikawada E, Stanley ER, Kelley VR (2003) Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170:3254–3262
Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β. Annu Rev Immunol 16:137–161
Li J, Qu X, Yao J, Caruana G, Ricardo SD, Yamamoto Y, Yamamoto H, Bertram JF (2010) Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 59:2612–2624
Li Y, Tan X, Dai C, Stolz DB, Wang D, Liu Y (2009) Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 20:1907–1918
Liu Y (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15:1–12
López-Novoa JM, Bernabeu C (2010) The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol 299:H959–H974
López-Novoa JM, Nieto MA (2009) Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1:303–314
López-Novoa JM, Martínez-Salgado C, Rodríguez-Peña AB, López-Hernández FJ (2010) Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives. Pharmacol Ther 128:61–81
López-Novoa JM, Rodríguez-Peña AB, Ortiz A, Martínez-Salgado C, López-Hernández FJ (2011) Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med 9:13
MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE (1989) Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160–1167
Martínez-Salgado C, Rodríguez-Peña AB, López-Novoa JM (2008) Involvement of small Ras GTPases and their effectors in chronic renal disease. Cell Mol Life Sci 65:477–492
Massagué J (1990) The transforming growth factor-family. Annu Rev Cell Biol 6:597–641
Massagué J, Chen YG (2000) Controlling TGF-β signaling. Genes Dev 14:627–644
McKay NG, Khong TF, Haites NE, Power DA (1993) The effect of transforming growth factor-1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing. Exp Mol Pathol 59:211–224
Meldrum KK, Metcalfe P, Leslie JA, Misseri R, Hile KL, Meldrum DR (2006) TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res 131:182–188
Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK (2005) TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 288:F406–F411
Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D (2000) Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301–2313
Mozes MM, Böttinger EP, Jacot TA, Kopp JB (1999) Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. J Am Soc Nephrol 10:271–280
Nam BY, Paeng J, Kim SH, Lee SH, Kim DH, Kang HY, Li JJ, Kwak SJ, Park JT, Yoo TH, Han SH, Kim DK, Kang SW (2011) The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions. Apoptosis (in press)
Nath KA (1992) Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1–17
Navar LG (2009) Glomerular permeability: a never-ending saga. Am J Physiol Renal Physiol 296:F1266–F1268
Norman JT, Fine LG (1999) Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp Nephrol 7:167–177
Nyengaard JR, Rasch R (1993) The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36:189–194
Okoń K, Sułowicz W, Smoleński O, Sydor A, Chruściel B, Kirker-Nowak A, Rosiek Z, Sysło K, Stachura J (2007) Interstitial, tubular and vascular factors in progression of primary glomerulonephritis. Pol J Pathol 58:73–78
Poncelet AC, Schnaper HW (1998) Regulation of mesangial cell collagen turnover by transforming growth factor-beta1. Am J Physiol Renal Physiol 275:F458–F466
Poncelet AC, Caestecker MP de, Schnaper HW (1999) The TGF-beta/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 56:1354–1365
Regoli M, Bendayan M (1997) Alterations in the expression of the alpha 3 beta1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus. Diabetologia 40:15–22
Remuzzi G, Benigni A, Remuzzi A (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116:288–296
US Renal Data System (2002) Annual Data Report: Atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
Roberts AB, McCune BK, Sporn MB (1992) TGF-beta: regulation of extracellular matrix. Kidney Int 41:557–559
Rodríguez-Barbero A, Obreo J, Eleno N, Rodríguez-Peña A, Düwel A, Jerkic M, Sánchez-Rodríguez A, Bernabéu C, López-Novoa JM (2001) Endoglin expression in human and rat mesangial cells and its upregulation by TGF-beta1. Biochem Biophys Res Commun 282:142–147
Rodríguez-Barbero A, Dorado F, Velasco S, Pandiella A, Banas B, López-Novoa JM (2006) TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int 70:901–909
Rodríguez-Peña A, Prieto M, Duwel A, Rivas JV, Eleno N, Pérez-Barriocanal F, Arévalo M, Smith JD, Vary CP, Bernabeu C, López-Novoa JM (2001) Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction. Nephrol Dial Transplant 16 (Suppl 1):34–39
Rodríguez-Peña A, Eleno N, Düwell A, Arévalo M, Pérez-Barriocanal F, Flores O, Docherty N, Bernabeu C, Letarte M, López-Novoa JM (2002) Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 40:713–720
Rodríguez-Peña AB, Grande MT, Eleno N, Arévalo M, Guerrero C, Santos E, López-Novoa JM (2008) Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int 74:196–209
Ruiz-Ortega M, Lorenzo O, Ruperez M, Blanco J, Egido J (2001) Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 158:1743–1756
Ruiz-Ortega M, Rupérez M, Esteban V, Rodríguez-Vita J, Sánchez-López E, Carvajal G, Egido J (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21:16–20
Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112:1486–1494
Schiffer M, Bitzer M, Roberts IS, Kopp JB, Dijke P ten, Mundel P, Bottinger EP (2001) Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108:807–816
Schlöndorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179–1187
Schnaper HW, Jandeska S, Runyan CE, Hubchak SC, Basu RK, Curley JF, Smith RD, Hayashida T (2009) TGF-β signal transduction in chronic kidney disease. Front Biosci 14:2448–2465
Schull MMI, Ormsby I, Kier AM, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata M, Doetschman T (1992) Targeted disruption of the mouse transforming growth factor-b1 gene results in multifocal inflammatory disease. Nature (Lond) 359:693–699
Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS (1999) Congenital nephritic syndrome in mice lacking CD2-associated protein. Science 286:312–315
Siegel PM, Massagué J (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3:807–820
Sinuani I, Beberashvili I, Averbukh Z, Cohn M, Gitelman I, Weissgarten J (2010) Mesangial cells initiate compensatory tubular cell hypertrophy. Am J Nephrol 31:326–331
Srivastava T, Garola RE, Whiting JM, Alon US (2001) Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 59:118–125
Steffes MW, Schmidt D, McCrery R, Basgen JM (2001) Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59:2104–2113
Strutz F, Neilson EG (2003) New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 24:459–476
Suzuki S, Ebihara I, Tomino Y, Koide H (1993) Transcriptional activation of matrix genes by transforming growth factor beta1 in mesangial cells. Exp Nephrol 1:229–237
Tamaki K, Okuda S (2003) Role of TGF-β in the progression of renal fibrosis. Contrib Nephrol 139:44–65
Tian M, Schiemann WP (2009) The TGF-beta paradox in human cancer: an update. Future Oncol 5:259–271
Urushihara M, Takamatsu M, Shimizu M, Kondo S, Kinoshita Y, Suga K, Kitamura A, Matsuura S, Yoshizumi M, Tamaki T, Kawachi H, Kagami S (2010) ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis. Am J Physiol Renal Physiol 298:F167–F176
Van Vliet A, Baelde HJ, Vleming LJ, Heer E de, Bruijn JA (2001) Distribution of fibronectin isoforms in human renal disease. J Pathol 193:256–262
Vleming LJ, Bruijn JA, Es LA van (1999) The pathogenesis of progressive renal failure. Neth J Med 54:114–128
Wahab NA, Weston BS, Roberts T, Mason RM (2002) Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol 13:2437–2445
Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB (1987) Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Pro Natl Acad Sci USA 84:5788–5792
Wang S-N, LaPage J, Hirschberg R (2000) Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57:1002–1014
Weston BS, Wahab NA, Mason RM (2003) CTGF mediates TGF-β-induced fibronectin matrix deposition by upregulating active α5β1 integrin in human mesangial cells. J Am Soc Nephrol 14:601–610
Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC (2005) Podocyte depletion causes glomerulosclerosis: diphtheria toxin–induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16:2941–2952
Wolf G (1998) Link between angiotensin II and TGF-beta in the kidney. Miner Electrolyte Metab 24:174–180
Wolf G (2006) Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-β pathway. Kidney Int 70:1914–1919
Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of glomerular capillary wall toward the center of the disease. Podocyte injury comes on age in diabetic nephropathy. Diabetes 54:1626–1634
Xie L, Law BK, Chytil AM et al (2004) Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6:603–610
Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H (2004) Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 53:1831–1840
Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S (1993) Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154–163
Zavadil J, Böttinger EP (2005) TGF-β and epithelial-to-mesenchymal transitions. Oncogene 24:5764–5774
Zeisberg M, Kalluri R (2008) Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr Nephrol 23:1395–1398
Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964–968
Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19:2282–2287
Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z, Oudit GY (2011) Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme. Hypertension 57:314–322
Ziyadeh FN (2008) Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Diabetes Res Clin Pract 82 (Suppl 1):S38–S41
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López-Hernández, F.J., López-Novoa, J.M. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347, 141–154 (2012). https://doi.org/10.1007/s00441-011-1275-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-011-1275-6